CSL

At CSL, we are proud to honor the rich cultural heritage, history, and contributions of the Hispanic and Latino communities. From September 15 to October 15, we celebrate the vibrant traditions, diverse cultures, and remarkable achievements that have shaped our society. Join us in recognizing and appreciating the invaluable impact of Hispanic and Latino individuals in our community and beyond. Let’s continue to embrace diversity, promote inclusion, and build a future where everyone can thrive. #HispanicHeritageMonth #CSL #DiversityAndInclusion #CelebrateCulture

Along with our partner Arcturus Therapeutics, we are proud to announce that Japan's Ministry of Health, Labor, and Welfare has approved our updated self-amplifying COVID-19 vaccine for protection against the JN.1 lineage of Omicron subvariants. At CSL, we are committed to delivering innovative technologies to combat COVID-19 and other respiratory diseases. Read more here: https://prn.to/3TuX5kp.

At CSL, we believe that our success is built on the foundation of diversity. Our team thrives because we bring together a unique mix of backgrounds, perspectives, and experiences. Whether you’re just starting your career or have years of expertise, there’s a place for you at CSL. We hire at a variety of skill and education levels, ensuring that everyone has the opportunity to contribute and grow. Join us and be part of a team where your individuality is celebrated and your potential is limitless. https://bit.ly/4dYjizN #Diversity #Inclusion #TeamCSL #CareerGrowth #JoinUs

On 17 September, the World Health Organization (WHO) marks #WorldPatientSafetyDay, a day to focus on how to keep patients safe when they receive medical care. CSL will join in the celebration with its own Patient Safety Week (September 16-20) that includes in-person and virtual events for employees. https://bit.ly/3XnUkTd

Watch as Prof Steven Pipe, University of Michigan, talks about his role as a Scientific Committee Member in the Prof Heimburger Award process and shares advice on applying. The Prof Heimburger Award has been established to honor the achievements of Prof Dr. Norbert Heimburger in pioneering modern coagulation therapy during his 30 years at CSL Behring. In the 18 years of its running, 85 promising coagulations specialists from all over the world have benefited from receiving the Prof Heimburger Award grant. This year again, 5 early-career specialists will be awarded €25,000 grants to support their innovative coagulation research. If you think that this could be you, simply submit your proposal through the Prof Heimburger Award website. Applications must be received by 11:59pm CET, November 11, 2024 to be considered. Please be aware that applications must meet eligibility criteria. See here for details: https://bit.ly/3Ts5mG1

At the 37th Inventors' Lab of the Center for Chemistry, CSL in Marburg offered talented students a unique opportunity to immerse themselves in the world of research and development and gain insights into possible career paths. https://bit.ly/3ZgyHXA

At CSL, our commitment goes beyond lifesaving therapies. We build support systems and partner with patient advocacy groups to create a strong community. #PatientStories Learn more: https://bit.ly/4d37dbb

At CSL, our culture celebrates diversity, ensuring everyone feels a sense of belonging. With equal opportunities for growth and a commitment to your success, join us in shaping a future where everyone thrives: https://bit.ly/3Zdw7BD #PromisingFutures #CSL

MTPConnect has launched a $28.5M Accelerator backing home-grown start-up Innovations for Heart Disease and Diabetes and CSL is a proud partner.   Professor Bronwyn Kingwell, Research Portfolio Strategy and Therapeutic Area Lead at CSL says our support of this research commercialisation Accelerator dovetails nicely with our long-term commitment to supporting Australia’s biotech ecosystem. “With the Accelerator’s support, we hope to see increased therapeutic development in cardiovascular disease and diabetes to benefit patients in Australia and around the world,” she said. #CSL

We are thrilled to announce the opening of our new state-of-the-art Multicube manufacturing facility in St. Gallen, Switzerland! With a modular design that can grow cube by cube and sustainability features like heat recovery and on-site solar power, we're set to meet the rising global demand for iron-based therapies. Discover how we're innovating for a healthier, more sustainable future. Watch the video and read more! https://bit.ly/47gJaUS #CSLVifor #Innovation #Sustainability #Healthcare #IronTherapies